The frataxin fusion protein (TAT-FXN) was delivered to different tissues, including heart, DRG, and cerebellum, and to the mitochondria, boosting respiratory chain activity and positively increasing the life span of the conditional heart model with a partial recovery of cardiomyopathy [210]. The gene discussed is FXN; the disease is cardiomyopathy.